XML 31 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Schedule of reconciliation of cash and cash equivalents
The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December 31, 2019, 2018 and 2017:
In millions
2019
 
2018
 
2017
Cash and cash equivalents
$
5,683

 
$
4,059

 
$
1,696

Restricted cash (included in other current assets)

 
6

 
14

Restricted cash (included in other assets)
271

 
230

 
190

Total cash, cash equivalents and restricted cash at the end of the period in the consolidated statements of cash flows
$
5,954

 
$
4,295

 
$
1,900



Schedule of accounts receivable, net Accounts receivable, net is composed of the following at December 31, 2019 and 2018:
In millions
2019
    
2018
Trade receivables
$
6,717

 
$
6,497

Vendor and manufacturer receivables
7,856

 
7,315

Premium receivables
2,663

 
2,259

Other receivables
2,381

 
1,560

   Total accounts receivable, net
$
19,617

 
$
17,631


Schedule of allowance for doubtful accounts
The activity in the allowance for doubtful accounts receivable for the years ended December 31, 2019, 2018 and 2017 is as follows:
In millions
2019
    
2018
 
2017
Beginning balance
$
287

 
$
162

 
$
158

Additions charged to bad debt expense
111

 
162

 
139

Write-offs charged to allowance
(79
)
 
(37
)
 
(135
)
Ending balance
$
319

 
$
287

 
$
162


Schedule of property and equipment
Property and equipment consists of the following at December 31, 2019 and 2018:
In millions
2019
    
2018
Land
$
1,981

 
$
1,872

Building and improvements
4,068

 
3,785

Fixtures and equipment
13,807

 
13,028

Leasehold improvements
5,611

 
5,384

Software
3,467

 
2,800

Total property and equipment
28,934

 
26,869

Accumulated depreciation and amortization
(16,890
)
 
(15,520
)
Property and equipment, net
$
12,044

 
$
11,349


Schedule of disaggregation of revenue
The following table disaggregates the Company’s revenue by major source in each segment for the years ended December 31, 2019 and 2018:
In millions
Pharmacy
Services
    
Retail/
LTC
    
Health Care
Benefits
 
Corporate/
Other
 
Intersegment
Eliminations
    
Consolidated
Totals
2019
 
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
140,896

 
$
66,442

 
$

 
$

 
$
(41,439
)
 
$
165,899

Front Store

 
19,422

 

 

 

 
19,422

Premiums

 

 
63,031

 
91

 

 
63,122

Net investment income

 

 
599

 
412

 

 
1,011

Other
595

 
744

 
5,974

 
9

 

 
7,322

Total
$
141,491

 
$
86,608

 
$
69,604

 
$
512

 
$
(41,439
)
 
$
256,776

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1)
$
88,755

 
 
 
 
 
 
 
 
 
 
Mail choice (2)
52,141

 
 
 
 
 
 
 
 
 
 
Other
595

 
 
 
 
 
 
 
 
 
 
Total
$
141,491

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2018
 
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
134,216

 
$
64,179

 
$
164

 
$

 
$
(33,714
)
 
$
164,845

Front Store

 
19,055

 

 

 

 
19,055

Premiums

 

 
8,180

 
4

 

 
8,184

Net investment income

 

 
58

 
602

 

 
660

Other
520

 
755

 
560

 

 

 
1,835

Total
$
134,736

 
$
83,989

 
$
8,962

 
$
606

 
$
(33,714
)
 
$
194,579

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1) (3)
$
87,167

 
 
 
 
 
 
 
 
 
 
Mail choice (2) (3)
47,049

 
 
 
 
 
 
 
 
 
 
Other
520

 
 
 
 
 
 
 
 
 
 
Total
$
134,736

 
 
 
 
 
 
 
 
 
 
_____________________________________________ 
(1)
Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company’s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice® activity, which is included within the mail choice category. Maintenance choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.
(2)
Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect® claims picked up at a retail pharmacy, as well as prescriptions filled at the Company’s retail pharmacies under the Maintenance Choice program.
(3)
Certain prior year amounts have been reclassified for consistency with the current period presentation.
Schedule of contract with customer assets and liabilities
The following table provides information about receivables and contract liabilities from contracts with customers as of December 31, 2019 and 2018:
In millions
2019
    
2018
Trade receivables (included in accounts receivable, net)
$
6,717

 
$
6,497

Contract liabilities (included in accrued expenses)
73

 
67


During the year ended December 31, 2019, the contract liabilities balance includes increases related to customers’ earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:
In millions
2019
    
2018
Balance at December 31, 2018
$
67

 
$
53

Adoption of ASU 2014-09

 
17

Rewards earnings and gift card issuances
365

 
332

Redemption and breakage
(359
)
 
(335
)
Balance at December 31, 2019
$
73

 
$
67


Schedule of variable interest entities
The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December 31, 2019 and 2018 was as follows:
In millions
2019
    
2018
Hedge fund investments
$
271

 
$
270

Private equity investments
538

 
524

Real estate partnerships
212

 
275

Total
$
1,021

 
$
1,069


Schedule of discontinued operations Below is a summary of the results of discontinued operations for the year ended December 31, 2017:
In millions
2017
Loss from discontinued operations
$
(13
)
Income tax benefit
5

Loss from discontinued operations, net of tax
$
(8
)

Schedule of new accounting pronouncements
As a result of applying the new lease accounting standard using a modified retrospective method, the following adjustments were made to accounts on the consolidated balance sheet as of January 1, 2019:
 
Impact of Change in Accounting Policy
In millions
As Reported
December 31, 2018
 
Adjustments
 
As Adjusted
January 1, 2019
Consolidated Balance Sheets:
 
 
 
 
 
Other current assets
$
4,581

 
$
(48
)
 
$
4,533

Total current assets
45,243

 
(48
)
 
45,195

Property and equipment, net
11,349

 
11

 
11,360

Operating lease right-of-use assets

 
20,987

 
20,987

Intangible assets, net
36,524

 
(217
)
 
36,307

Other assets
5,046

 
(521
)
 
4,525

Total assets
196,456

 
20,212

 
216,668

Accrued expenses
10,711

 
(52
)
 
10,659

Current portion of operating lease liabilities

 
1,803

 
1,803

Current portion of long-term debt
1,265

 
2

 
1,267

Total current liabilities
44,009

 
1,753

 
45,762

Long-term operating lease liabilities

 
18,832

 
18,832

Long-term debt
71,444

 
(96
)
 
71,348

Deferred income taxes
7,677

 
63

 
7,740

Other long-term liabilities
2,780

 
(518
)
 
2,262

Total liabilities
137,913

 
20,034

 
157,947

Retained earnings
40,911

 
178

 
41,089

Total CVS Health shareholders’ equity
58,225

 
178

 
58,403

Total shareholders’ equity
58,543

 
178

 
58,721